You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

MILONTIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Milontin patents expire, and when can generic versions of Milontin launch?

Milontin is a drug marketed by Parke Davis and is included in one NDA.

The generic ingredient in MILONTIN is phensuximide. Additional details are available on the phensuximide profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MILONTIN?
  • What are the global sales for MILONTIN?
  • What is Average Wholesale Price for MILONTIN?
Summary for MILONTIN
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 56
Patent Applications: 2,249
DailyMed Link:MILONTIN at DailyMed
Drug patent expirations by year for MILONTIN

US Patents and Regulatory Information for MILONTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis MILONTIN phensuximide CAPSULE;ORAL 008855-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

MILONTIN Market Analysis and Financial Projection Experimental

Melatonin Market Dynamics and Financial Trajectory

Introduction

Melatonin, a hormone that regulates sleep-wake cycles, has become a significant player in the global health and wellness market. The melatonin market is characterized by dynamic shifts in supply and demand, influenced by various factors including consumer behavior, production capacities, and regulatory environments.

Global Melatonin Market Overview

The global melatonin market is experiencing rapid growth, driven by increasing awareness of sleep disorders and the benefits of melatonin supplementation. As of 2024, the melatonin market was valued at USD 1.86 billion and is projected to reach USD 4.93 billion by 2031, growing at a CAGR of 14.30% from 2024 to 2031[4].

Market Drivers

Several key factors are driving the growth of the melatonin market:

Increased Awareness of Sleep Disorders

The rising awareness of sleep disorders and their impact on health has led to an increased demand for melatonin supplements. This trend is particularly pronounced in regions with high stress levels and aging populations[4].

Technological Advances

Advances in melatonin product formulations have expanded the range of available products, making them more appealing to a broader consumer base. Innovations in delivery systems, such as timed-release formulations and gummies, have also contributed to market growth[4].

Growing Online Retail Sector

The expansion of the online retail sector has made melatonin supplements more accessible to consumers worldwide. This ease of access has significantly boosted sales and market penetration[4].

Shift Toward Natural Health Therapies

There is a growing preference for natural health therapies over traditional pharmaceuticals, which has further fueled the demand for melatonin supplements. Consumers are increasingly seeking holistic approaches to health and wellness[4].

Regional Market Analysis

North America

North America holds a significant share of the melatonin market, driven by high consumer awareness and a strong retail infrastructure. The U.S. market, in particular, faces challenges such as supply chain disruptions, which have impacted local manufacturers' ability to meet demand[1].

Asia-Pacific

The Asia-Pacific region, including China, is a major production hub for melatonin. China's local nutraceutical market has seen increased vibrancy, with manufacturers ramping up production to meet growing domestic and international demand. However, factors such as holiday closures and planned plant maintenance shutdowns have introduced volatility into the market[1].

Supply and Demand Dynamics

Q2 2024 Market Trends

During the second quarter of 2024, the melatonin market experienced significant price fluctuations. Initially, prices rose due to robust demand from downstream industries, particularly in China. However, as the quarter progressed, prices declined due to factors such as Labor Day holiday closures in China, subdued actual sales, and a cautious approach by market participants[1].

Inventory Management

Moderate inventory levels and limited new inquiries from international buyers have characterized the market. To manage inventory and stimulate demand, manufacturers and suppliers have implemented strategic price reductions. This strategy is crucial, especially with planned plant maintenance shutdowns scheduled for mid-July to early September, which could further impact melatonin prices[1].

Financial Trajectory

Revenue Projections

The melatonin market is expected to continue its upward trajectory, with revenues projected to reach USD 4.93 billion by 2031. This growth is driven by the increasing demand for melatonin supplements across various regions and the expanding online retail sector[4].

Competitive Landscape

Key industry participants such as Natrol, Life Extension, and Swanson Health Products are focusing on product innovation and strategic collaborations to strengthen their market positions. These strategies are essential for maintaining competitiveness in a market characterized by high demand and competitive pressures[4].

Challenges and Opportunities

Supply Chain Issues

Supply chain disruptions, such as severe congestion at U.S. ports, have extended wait times for cargo and delayed supply retrieval. These issues necessitate robust supply chain management strategies to ensure continuous supply and meet growing demand[1].

Regulatory Environment

The regulatory environment plays a crucial role in shaping the melatonin market. Approvals and regulations can significantly impact the availability and adoption of melatonin products. Manufacturers must stay vigilant and adapt to changing regulatory landscapes to maintain market competitiveness[1].

Key Takeaways

  • The global melatonin market is projected to grow significantly, driven by increased awareness of sleep disorders and technological advances.
  • Regional markets, such as North America and the Asia-Pacific, are key drivers of this growth.
  • Supply and demand dynamics are influenced by factors such as holiday closures, inventory levels, and supply chain disruptions.
  • Manufacturers are implementing strategic price reductions and focusing on product innovation to manage inventory and stimulate demand.
  • The market is expected to reach USD 4.93 billion by 2031, with a CAGR of 14.30% from 2024 to 2031.

FAQs

What are the primary drivers of the melatonin market growth?

The primary drivers include increased awareness of sleep disorders, technological advances in product formulations, the growing online retail sector, and a shift toward natural health therapies[4].

How has the supply chain impacted the melatonin market in 2024?

Supply chain disruptions, such as severe congestion at U.S. ports and planned plant maintenance shutdowns, have extended wait times for cargo and delayed supply retrieval, affecting the market's stability[1].

What is the projected market size of the melatonin market by 2031?

The melatonin market is projected to reach USD 4.93 billion by 2031, growing at a CAGR of 14.30% from 2024 to 2031[4].

Which regions are significant in the melatonin market?

North America and the Asia-Pacific region, particularly China, are significant in the melatonin market due to high consumer awareness and robust production capacities[1][4].

How are manufacturers adapting to market challenges?

Manufacturers are implementing strategic price reductions, focusing on product innovation, and engaging in strategic collaborations to manage inventory levels and stimulate demand[1][4].

Sources

  1. ChemAnalyst - Quarterly News Report: Melatonin Market Dynamics in Q2 2024
  2. Cambridge University Press - 1945–1970: Epilepsy and the New World Order
  3. GlobeNewswire - Multiple Sclerosis Drugs Market Outlook and Strategic Business Report 2024-2030
  4. Verified Market Research - Melatonin Market Size, Share, Scope, Trends, Growth & Forecast
  5. Arkansas State Legislature - RULES AND REGULATIONS Governing GREYHOUND RACING In ... (Not cited in the response)

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.